Company:  PUMA BIOTECHNOLOGY, INC. (PBYI)
Form Type:  10-Q
Filing Date:  5/9/2013 
CIK:  0001401667 
Address:  10880 WILSHIRE BLVD.
SUITE 2150
 
City, State, Zip:  LOS ANGELES, California 90024 
Telephone:  (424) 248-6500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$77.37  
Change: 
-0.46 (-0.59%)  
Trade Time: 
04:02 PM EST  
Market Cap: 
$2.33B
Description of Business
Unless otherwise provided in this Annual Report, references to the �Company,� �we,� �us,� and �our� refer to Puma Biotechnology, Inc., a Delaware corporation formed on April 27, 2007 and formerly known as Innovative Acquisitions Corp., together with its wholly-owned subsidiary, Puma Biotechnology Ltd., and all references to �Former Puma� refer to Puma Biotechnology, Inc., a privately-held Delaware corporation formed on September 15, 2010, that merged with and into us in October 2011. We refer to this transaction as the �Merger.� We are a development stage biopharmaceutical company with a focus on the acquisition, development and commercialization of innovative products to enhance cancer care. We aim to acquire proprietary rights to these products, by license or otherwise, fund their research and development and bring the products to market.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    Part I - FINANCIAL INFORMATION
      Item 1. Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      Item 1. LEGAL PROCEEDINGS
      Item 1A. RISK FACTORS
      Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      Item 3. DEFAULTS UPON SENIOR SECURITIES
      Item 4. MINE SAFETY DISCLOSURES
      Item 5. OTHER INFORMATION
      Item 6. EXHIBITS
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION
  EXHIBIT 32.2
    CERTIFICATION
BROKERAGE PARTNERS